Smartfem is an Australian medtech company pioneering first-in-class autologous regenerative medicine technologies for pelvic floor reconstruction and gynaecological applications. Combining advanced biomedical engineering, regenerative medicine, and surgical innovation, Smartfem is developing non-synthetic, non-hormonal, patient-derived graft systems designed to support tissue repair, improve healing, and enhance surgical outcomes, with a strong focus on clinical evidence, regulatory advancement, and global commercialisation.